
TY  - JOUR
TI  - Haematology and oncology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_4.x
DO  - doi:10.1111/j.1365-2362.2005.1478_4.x
SP  - A70
EP  - A78
PY  - 2005
ER  - 

TY  - JOUR
TI  - Lipids
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_6.x
DO  - doi:10.1111/j.1365-2362.2005.1478_6.x
SP  - A88
EP  - A92
PY  - 2005
ER  - 

TY  - JOUR
TI  - Nephrology and hypertension
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_7.x
DO  - doi:10.1111/j.1365-2362.2005.1478_7.x
SP  - A93
EP  - A99
PY  - 2005
ER  - 

TY  - JOUR
TI  - Immunology, rheumatology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_5.x
DO  - doi:10.1111/j.1365-2362.2005.1478_5.x
SP  - A79
EP  - A87
PY  - 2005
ER  - 

TY  - JOUR
TI  - Neurology and neurobiology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_8.x
DO  - doi:10.1111/j.1365-2362.2005.1478_8.x
SP  - A100
EP  - A105
PY  - 2005
ER  - 

TY  - JOUR
TI  - Thrombosis and haemostasis
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_10.x
DO  - doi:10.1111/j.1365-2362.2005.1478_10.x
SP  - A108
EP  - A114
PY  - 2005
ER  - 

TY  - JOUR
TI  - Gastroenterology and hepatology
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - s2
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.1478_3.x
DO  - doi:10.1111/j.1365-2362.2005.1478_3.x
SP  - A60
EP  - A69
PY  - 2005
ER  - 

TY  - JOUR
TI  - Tuesday 30 August 2011
JO  - Journal of Neurochemistry
VL  - 118
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1471-4159.2011.07325.x
DO  - doi:10.1111/j.1471-4159.2011.07325.x
SP  - 84
EP  - 164
PY  - 2011
ER  - 

TY  - JOUR
TI  - General abstracts (in alphabetical order by presenting underlined author)
JO  - American Journal of Reproductive Immunology
JA  - Am J Reprod Immunol
VL  - 76
IS  - S1
SN  - 1046-7408
UR  - https://doi.org/10.1111/aji.12581
DO  - doi:10.1111/aji.12581
SP  - 29
EP  - 62
PY  - 2016
ER  - 

TY  - JOUR
TI  - ASBMR 31st Annual Meeting SA0001â€“SA0464
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 24
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650241303
DO  - doi:10.1002/jbmr.5650241303
SP  - S150
EP  - S236
PY  - 2009
ER  - 

TY  - JOUR
AU  - Grover, V. P. B.
AU  - Pavese, N.
AU  - Koh, S.-B.
AU  - Wylezinska, M.
AU  - Saxby, B. K.
AU  - Gerhard, A.
AU  - Forton, D. M.
AU  - Brooks, D. J.
AU  - Thomas, H. C.
AU  - Taylor-Robinson, S. D.
TI  - Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
JO  - Journal of Viral Hepatitis
VL  - 19
IS  - 2
SN  - 1352-0504
UR  - https://doi.org/10.1111/j.1365-2893.2011.01510.x
DO  - doi:10.1111/j.1365-2893.2011.01510.x
SP  - e89
EP  - e96
KW  - cognitive function
KW  - hepatitis C
KW  - magnetic resonance spectroscopy
KW  - positron emission tomography
PY  - 2012
AB  - Summary.? Patients with chronic hepatitis C infection may exhibit neuropsychological symptoms and cognitive impairment. Post-mortem studies of hepatitis C virus HCV quasispecies and replicative intermediates indicate that the brain might act as a separate compartment for viral replication and microglia may be the locus for infection and subsequent neuroinflammatory activity. We sought to use two independent in vivo imaging techniques to determine evidence of neuroinflammation in patients with histologically mild chronic hepatitis C. Using positron emission tomography (PET) with a ligand for microglial/brain macrophage activation, 11C-(R)-PK11195 (PK11195) and cerebral proton magnetic resonance spectroscopy, we determined whether there was evidence of neuroinflammation in a pilot study of 11 patients with biopsy-proven mild chronic hepatitis C, compared to healthy volunteers. Patients were characterized by cognitive testing and the fatigue impact scale to assess for CNS impairment. PK11195 binding potential was significantly increased in the caudate nucleus of patients, compared to normal controls (P?=?0.03). The caudate and thalamic binding potential were more significantly increased in six patients with genotype 1 infection (P?=?0.007) and positively correlated with viraemia (r?=?0.77, P?=?0.005). Basal ganglia myo-inositol/creatine and choline/creatine ratios were also significantly elevated in patients with chronic hepatitis C compared to normal controls (P?=?0.0004 and P?=?0.01, respectively). Using PET, we demonstrated evidence of microglial activation, which positively correlated with HCV viraemia and altered cerebral metabolism in the brains of patients with mild hepatitis C. This provides further in vivo evidence for a neurotropic role for HCV.
ER  - 

TY  - JOUR
AU  - Brightling, C. E.
AU  - Gupta, S.
AU  - Gonem, S.
AU  - Siddiqui, S.
TI  - Lung damage and airway remodelling in severe asthma
JO  - Clinical & Experimental Allergy
JA  - Clin Exp Allergy
VL  - 42
IS  - 5
SN  - 0954-7894
UR  - https://doi.org/10.1111/j.1365-2222.2011.03917.x
DO  - doi:10.1111/j.1365-2222.2011.03917.x
SP  - 638
EP  - 649
PY  - 2012
AB  - Summary Severe asthma is a heterogeneous disease with substantial unmet clinical need. Airway damage and remodelling is a consequence of complex host?environment interactions and is considered to be the cardinal feature leading onto the development and persistence of airflow obstruction. In this review, we shall bring together recent insights into the causes of airway damage and remodelling that propose key roles for pathogens and mechanical damage in addition to allergens, underlying genetic susceptibility, inflammatory and structural cell interactions, and impaired resolution of damage. We shall consider the consequences of airway remodelling in terms of airway geometry, mechanics and clinical expression of disease. Understanding the causes and consequences of airway damage and remodelling will shed light upon the structure?function relationships required to begin to unravel the complexity of severe asthma and will enable us to target current and novel therapies as we begin to move towards realizing personalized medicine.
ER  - 

TY  - JOUR
TI  - Author Index
JO  - Clinical & Experimental Immunology
VL  - 145
IS  - 3
SN  - 0009-9104
UR  - https://doi.org/10.1111/j.1365-2249.2006.03201.x
DO  - doi:10.1111/j.1365-2249.2006.03201.x
SP  - 573
EP  - 578
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - BJU International
JA  - BJU Int
VL  - 113
IS  - S5
SN  - 1464-4096
UR  - https://doi.org/10.1111/bju.12760
DO  - doi:10.1111/bju.12760
SP  - 19
EP  - 67
PY  - 2014
ER  - 

TY  - JOUR
TI  - Trauma
JO  - ANZ Journal of Surgery
VL  - 78
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2008.04520.x
DO  - doi:10.1111/j.1445-2197.2008.04520.x
SP  - A138
EP  - A150
PY  - 2008
ER  - 

AU  - McConachie, Erin L.
AU  - Hart, Kelsey A.
C7  - pp. 153-172
TI  - Inflammation, Endotoxemia and Systemic Inflammatory Response Syndrome
SN  - 9781118558874
UR  - https://doi.org/10.1002/9781119086512.ch18
DO  - doi:10.1002/9781119086512.ch18
SP  - 153-172
KW  - Corticosteroids
KW  - Corticosteroids
KW  - Endotoxemia
KW  - immune system
KW  - inflammation
KW  - sepsis
KW  - Systemic Inflammatory Response Syndrome
PY  - 2008
AB  - Summary Horses suffer from a long list of diseases in which inflammation is central to the pathogenesis of the primary disease process. When the inflammatory response extends beyond the local injured tissues, widespread systemic inflammation ensues and can generate the clinical syndrome known as the systemic inflammatory response syndrome (SIRS). The innate immune system is integral to the pathogenesis of the clinically recognized acute inflammatory disorders of SIRS, endotoxemia and sepsis syndromes. Coagulopathies are likely to exist in patients with moderate to severe systemic inflammation or endotoxemia, with variable clinicopathologic evidence of disordered hemostasis. Corticosteroids, theoretically, have many useful actions for fighting inflammation in endotoxemia, SIRS, and sepsis. Horses that recover from severe SIRS and sepsis are not necessarily at risk to have recurrent episodes of disease. However, inflammation-related end-organ damage might predispose them to organ failure or related complications in the future.
ER  - 

TY  - JOUR
TI  - American Society of Pediatric Hematology/Oncology 18th Annual Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 44
IS  - 6
SN  - 9781118558874
UR  - https://doi.org/10.1002/pbc.20423
DO  - doi:10.1002/pbc.20423
SP  - 529
EP  - 577
PY  - 2005
ER  - 

TY  - JOUR
TI  - Cytokines in growth, development and pathogenesis
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 50
IS  - S16B
SN  - 9781118558874
UR  - https://doi.org/10.1002/jcb.240500606
DO  - doi:10.1002/jcb.240500606
SP  - 267
EP  - 296
PY  - 1992
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Respirology
VL  - 14
IS  - s3
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1440-1843.2009.01657.x
DO  - doi:10.1111/j.1440-1843.2009.01657.x
SP  - A125
EP  - A169
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S2
SN  - 9781118558874
UR  - https://doi.org/10.1111/nep.12236_2
DO  - doi:10.1111/nep.12236_2
SP  - 26
EP  - 76
PY  - 2014
ER  - 
